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Abstract
Background: There have been an increasing number of reports world-wide relating improved outcomes
after pancreatic resections to high volumes thereby supporting the idea of centralization of pancreatic
resectional surgery. To date there has been no collective attempt from India at addressing this issue. This
cohort study analysed peri-operative outcomes after pancreatoduodenectomy (PD) at seven major Indian
centres.
Materials and Methods: Between January 2005 and December 2007, retrospective data on PDs,
including intra-operative and post-operative factors, were obtained from seven major centres for pan-
creatic surgery in India.
Results: Between January 2005 and December 2007, a total of 718 PDs were performed in India at the
seven centres. The median number of PDs performed per year was 34 (range 9–54). The median number
of PDs per surgeon per year was 16 (range 7–38). Ninety-four per cent of surgeries were performed for
suspected malignancy in the pancreatic head and periampullary region. The median mortality rate per
centre was four (range 2–5%). Wound infections were the commonest complication with a median
incidence per centre of 18% (range 9.3–32.2%), and the median post-operative duration of hospital stay
was 16 days (range 4–100 days).
Conclusions: This is the first multi-centric report of peri-operative outcomes of PD from India. The
results from these specialist centers are very acceptable, and appear to support the thrust towards
centralization.
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Introduction
There have been an increasing number of reports from around the
world relating improved outcomes after pancreatic resections to
high volumes of patients.1–8 This has led to an increased emphasis
on centralization of pancreatic resectional surgery, especially pan-
creatoduodenectomy (PD). PD remains a complex surgery with
an attendant high morbidity rate.9–11 The reduction in operative
mortality rates across the world, to less than 5%,12–14 has largely
been attributed to a vast variety of factors including specialized
surgery being performed in specialized centres,1–8 interventional
radiology support for management of complications15,16 and
better critical care support. In fact, Kotwall et al.,17 using the
Nationwide Inpatient Sample Database, showed a 50% excess
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mortality after PD in low-volume centres in the United States of
America. While there have been many Indian publications on
PDs,18–28 there are no studies reporting collated results from a
number of centres. This cohort study was carried out to determine
the peri-operative outcomes of PD from seven high-volume
centres in India.
Materials and methods
Between 1st January 2005 to 31st December 2007, retrospective
data of patients undergoing PDs in seven Indian high-volume
(more than five PDs per year1,29,30) Gastrointestinal and Hepato-
Pancreato-Biliary centres were reviewed. The participating centres
included Bhopal Memorial Hospital and Research Center
(BMHRC – Bhopal), Lakeshore Hospital (Cochin), Nizam’s Insti-
tute, Hyderabad, Sanjay Gandhi Post Graduate Institute of
Medical Sciences (SGPGI – Lucknow), Sir Ganga Ram Hospital
(SGRH – New Delhi), Stanley Medical College (Chennai) and Tata
Memorial Hospital (TMH – Mumbai).
All the seven centres included in the study are renowned super-
speciality teaching institutions located in different parts of India
and offer advanced training programmes in the field of Surgical
Gastroenterology. Moreover, all authors in the study are recog-
nized nationally as leaders in the field with publications to their
credit.
In India, there are many other centres performing PDs, and we
have not attempted to represent all PDs being performed in the
country. This study has been possible because of good personal
relations between the authors from the seven centres, and hope-
fully will set a precedent towards multi-centric data sharing within
India.
The data of the patients from each institute were collated by the
participating institute and a common proforma was filled out by
each individual institute and sent to the analysing centre (Tata
Memorial Hospital). Data of PDs performed at all the centers were
then collected in a proforma (See Table 1) and analysed.
Standard definitions were used for the classification of compli-
cations (See Table 1). Peri-operative mortality was defined as
deaths taking place during surgery, immediate post-operative
(irrespective of whether they arose as a result of the surgery or
other causes), up to 30 days post-operative or any death in a
patient outside these criteria that was directly related to a compli-
cation of the procedure.
Statistical analysis
All statistical analyses were performed using the Statistical
Product and Service Solutions, SPSS 14.0 for Windows (SPSS Inc.,
Chicago, IL, USA). Nominal data are provided as number (%) and
continuous data as median (range) and P  0.05 was regarded as
significance.
Pearson’s c2-test was used for testing associations between sur-
gical site and mortality rates.
Results
During the study period, 718 patients underwent PDs at these
seven centres. The median number of PDs performed per year
was 34 (range 9–54). The median number of PDs per surgeon
per year was 16 (range 7–38). The demographics, indications for
surgery, pre- and intra-operative factors are summarized in
Table 2.
Drug protocols
In the seven centres, all patients received peri-operative intrave-
nous third generation Cephalosporins which were continued for
3–7 days post-operatively. The preferred antibiotic combination
of cefoparazon-sulbactam was the preferred choice in four
centres, whereas cefotaxime (two centres) and ceftriaxone (1
centre) were also used. In patients who developed intraabdominal
complications including haemorrhage and post-operative pan-
creatic fistula (POPF), Meropenem was used.
The use of octreotide varied between institutes. While in three
centres octreotide was routinely used for 3–7 days post-operative,
in two other centers, the choice for octreotide was reserved only in
case of a soft pancreas and undilated pancreatic duct in which case
it was used for 5 and 7 days. In the 6th centre, in addition to the
previous two indications, octreotide was also used in case of a
technically unsatisfactory pancreaticoenterostomy. In the 7th
centre, octreotide was never used.
Drains
In all centres, surgical tube drains were routinely placed intra-
operatively. The number of drains used routinely varied from 2
in 3 centres to 1 in 2 centers. In the remaining 2 centres, the
number of drains used, 1 or 2, depended on the operating sur-
geon’s preference. In 5 centres the drains used were non-suction
drains, in the 6th centre closed suction drains were routinely used,
whereas in the 7th centre, the choice was dependant on the oper-
ating surgeon.
Histopathology
Final histology confirmed 643 (89.5%) patients with adenocarci-
noma, 35 (4.8%) chronic pancreatitis, 21 (2.9%) neuroendocrine
tumours, 8 (1.1%) solid pseudopapillary tumours and 15 (2%)
other pathology.
Post-operative morbidity and mortality
The median (range) individual complication rate per centre is
described in Table 3. Wound infections were the commonest
complication with a median incidence per centre of 18%
(range 9–32%). Post-operative pancreatic fistulae were the
second most common complication with a median incidence per
centre of 12% (6–38%). As per the International study Group on
Pancreatic Fistula (ISGPF) definition,32 the post-operative
pancreatic fistulae (n = 135) were of the following grades:
Grade A = 85 (62.9%), Grade B = 19 (14%) and Grade C = 31
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(22.9%). Forty four (6.1%) patients developed post-
operative bleeding. These included 13 patients with an
early bleed (<24 h) and 31 patients with a late bleed (>24 h).
Nineteen out of the 44 patients required re-surgery to control
the bleeding.
The median post-operative hospital stay was 16 days (range
4–100). Applying Pearson’s c2-test for association between surgi-
cal site and mortality rates, we found no significant association
(P < 0.796) between surgical site and mortality.
Discussion
The concept of improved outcomes for patients undergoing pan-
creatic resections at high volume centres is not new. Birkmeyer
et al.1 were the first to put forth this idea that was later ratified by
large studies from Europe and the United States.2–8
The current study was performed to analyse the pattern of
peri-operative outcomes for patients undergoing PDs in seven
Gastrointestinal and Hepato-Pancreato-Biliary Surgical Speciality
Table 1 Definition of complications
Factors studied Definitions used
Demographic data • Age
• Gender
Preoperative variables Number of patients undergoing preoperative biliary drainage (PTBD or ERCP with stenting, or cholecystostomy)
Indications for PD
Intra-operative factors • Type of resection – classicor pylorus-preserving
• Type of pancreaticoenteric anastomosis – PG or PJ
• Extent of lymph node dissection31 Standard – defined as regional lymphadenectomy around the duodenum and
pancreasRadical – regional lymphadenectomy plus skeletonisation hepatic arteries, superior mesenteric artery
between aorta and inferior pancreaticoduodenal, and celiac trunk, dissection of the anterolateral aspect of aorta
and vena cava including Gerota's fascia
• Use of pancreatic ductal stent and the indications
• Type of GJ / DJ – ante- or retro-colic
• Duration of surgery
• Blood loss
• Number of transfusions per patient
Peri-operative variables • Antibiotic protocol
• Use of octreotide
• Morbidity
I. Pancreatic fistula was defined as per the ISGPF32
II. Delayed gastric emptying – defined as either 1) nasogastric tube decompression for 10 days and one of the
following criteria: a) emesis after nasogastric tube removal, b) post-operative use of prokinetic agents after
post-operative day 10, c) reinsertion of a nasogastric tube, or d) failure to progress with diet, or 2) nasogastric
tube decompression for <10 days and two out of the four criteria.
III. Biliary leak – persistent biliary drainage form the drain placed in the right upper quadrant.
IV. Haemorrhage – bleeding as evidenced by the presence of fresh blood in the drains/nasogastric tube and/or
malaena, with or without the further need for intervention – radiological or surgical.
V. Acute pancreatitis – at least a threefold increase in the normal amylase or lipase serum value within the 4th
post-operative day, confirmed clinically and radiologically (CT)
VI. Fluid collection (Abscess) – fluid collection diagnosed on US or CT associated with presence of pus on guided
aspiration performed for clinical with leucocytosis/leucopenia (patients in septicemia), tachycardia and local
abdominal tenderness with or without prior evidence of acute pancreatitis and after removal of drains.
VII. Chyle leak – was defined as drainage of copious milky white fluid from the intra-operatively placed drains with
a normal drain amylase (<three times normal at any time post-operative)
VIII. Persistently high drain output – high volume (>50 cc/day) serous drain effluent with normal drain amylase and
non-chylous persisting after the first postoperative week.
• Mortality
Post-operative factors • Duration of hospital stay defined as the entire period of hospitalization until the patient was discharged
• Histopathology
PD, pancreatoduodenectomy; PTBD, percutaneous transhepatic biliary drainage; ERCP, endoscopic retrograde cholangiopancreatography;
PG, pancreaticogastrostomy; PJ, pancreaticojeunostomy; GJ, gastrojejunostomy; DJ, duodenojejunostomy; ISGPF, International study Group on
Pancreatic Fistula definition; US, ultrasonography; CT, computed tomography.
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and Teaching Hospitals across India. We used a cut-off value of
more than five PDs a year to define ‘high volume’ as has been
described by Birkmeyer and Kingsnorth.1,29,30
Unlike the recently published articles from Belgium and Italy7,8
addressing the issue of centralization, our study did not rely on
any central data-gathering agency. There is no systematic collec-
tion of the total number of surgical procedures performed in the
country, and it would be very difficult to quote any reliable peri-
operative outcome for the country as a whole. It is usually left to
individual centres or units to establish their own data-bases, and
maintain meticulous data capture and analysis.
From the data analysed, together, the centres performed a
median of 34 PDs a year (range 9–54) with a median individual
surgeon-volume of 16 surgeries per year over the 3-year study
period.
The antibiotic protocols were quite similar in all the seven
centres, with the cephalosporin group of antibiotics being the
most commonly used. While routine antibiotic prophylaxis is rec-
ommended in PD,33,34 the continued use of antibiotics up to the
7th post-operative day in our study possibly reflects an over-
cautious approach. There are reports from India regarding the use
of prophylactic antibiotics being inconsistent with published
guidelines.35
An earlier study from India36 had demonstrated the increased
risk of septic complications in patients undergoing PD in whom
the pre-operative endoscopic drainage was complicated. The
centres included in our study constitute referral centres, and
32.3% of patients had undergone pre-operative endoscopic drain-
age, which may not necessarily have been undertaken at the insti-
tute per se. Clearly, there appears a need to further rationalize and
develop evidence-based antibiotic prophylaxis policies which
would be applicable nationally.37
Use of Octreotide between centres was also variable. This is
probably a reflection of the lack of clear benefit of octreotide in
PD. Since 1992, five randomized controlled trials (RCT) have been
performed in Europe38–42 and one RCT in the US.43 While four out
of the five European studies38–41 did show a trend towards
improved peri-operative outcomes with the use of octreotide, the
5th study42 did not actually report any benefit in the entire patient
cohort. What was found though, on sub-group analysis, was that
Octreotide was useful in patients with a duct diameter of <3mm.
The lone RCT from the US43 failed to demonstrate any advantage
of Octreotide use in this setting.
The type of resection and reconstruction performed varied
between the centres with pylorus-preserving PDs being per-
formed in 321 patients (44.7%) and classic PDs being performed
in 397 patients (55.3%). This often appeared to be a protocol of
the centre although some units did appear to have specific
indications for performing classic PDs (in patients with
duodenal malignancies or pancreatic head lesions infiltrating the
duodenum).
Most patients underwent a standard lymphadenectomy, with
only 7.9% of patients being subjected to a radical lymphadenec-
Table 2 Patient-related factors including demography, indications
for PD and intra-operative factors
Demography
Median age (range) 53 years (13–88)
Male gender 435 (60.5%)
Pre-operative biliary tent 232 (32.3%)
Indications for PD
Neoplasms 668 (93.0%)
Lower CBD 108
Pancreatic head 180
Ampulla 299
Duodenum 81
Chronic pancreatitis 35 (4.8%)
Others 15 (2.0%)
Type of PD
Pylorus-preserving 321 (44.7%)
Classic 397 (55.3%)
Median (range) blood loss (mls) 400 (60–4000) ml
Median (range) duration of surgery (minutes) 245 (120–770) min
Type of pancreatic reconstruction
PJ 491 (68.3%)
PG 227 (31.7%)
Extent of lymph node dissectiona
Standard 652 (90.8%)
Radical 57 (7.9%)
Type of GJ /DJ
Antecolic 334 (46.5%)
Retrocolic 384 (53.5%)
aIn nine patients, a lymphadenectomy was not performed as per the
Institute's policy not to perform a lymphadenectomy for patients with
chronic pancreatitis.
PD, pancreatoduodenectomy; CBD, common bile duct; PG, pancreat-
icogastrostomy; PJ, pancreaticojeunostomy; GJ, gastrojejunostomy; DJ,
duodenojejunostomy.
Table 3 Outcomes and complications (n = 718)
Median incidence
rates (range)
Surgical complications
Wound infections 18 (9–32%)
Post-operative pancreatic fistula (n = 135) 12 (6–38%)
Delayed gastric emptying 10 (0–31%)
Haemorrhage 6 (3–13%)
Persistent high drain output 7 (0–13%)
Biliary leak 1 (0–17%)
Acute pancreatitis 6 (0–6%)
Chyle leak 4 (0–4%)
Mortality 3.57% (2–5%)
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tomy. A recent meta-analysis44 comparing standard PD versus
extended PD, that included three randomized controlled trials,
found that while extended PD increased lymph node yield and
reduced positive resection margins, it conferred no survival
advantage and was associated with a significantly increased risk of
delayed gastric emptying (DGE).
The choice of pancreatic anastomosis showed a trend towards
preference of pancreaticojejunostomy (PJ). PJ was performed in
491 patients (68.3%) as compared with a pancreaticogastrostomy
(PG) which was performed in 227 patients (31.7%). While two
meta-analyses45,46 covering three, randomized, controlled trials47–49
comparing PG versus PJ failed to show any statistically significant
benefit of one technique of anastomosis over the other in terms of
anastomotic leak rate, there is an increasing trend amongst sur-
geons towards performing a PJ.50 This appears to be reflected in
our study, as well.
The choice of the ante- versus retro-colic approach for gastroje-
junostomy was evenly spread (46.5% vs. 53.5% respectively).
While studies have reported a higher incidence of post-operative
DGE51–53 after the performance of a retrocolic GJ, a recent review
of literature by Traverso and Hashimoto54 found that conclusive
evidence as to the benefit of one technique over the other could
not be derived from the available literature owing to lack of
homogeneity of definition and design and also because of the fact
that the studies were underpowered.
Abdominal drains were routinely used in all seven centres.
However, the number and type of drains used varied between the
centres. This is possibly a reflection of the lack of consensus on the
use of drains reported from around the world. While some studies
have reported the lack of benefit of intraabdominal drains,55,56
others recommend drainage27,57 although the duration of drainage
varies.
Despite the variance in the peri- and intra-operative manage-
ment, the morbidity and mortality rates were within the observed
world standards.4–8,12–14 Post-operative pancreatic fistulae
accounted for 17% of the complications in the entire series of
which 77.0% were grade A and B. There appeared to be no sig-
nificant association between the surgical site and mortality rates.
This study, which represents data from seven leading pancreatic
surgery centres from India over a defined 3-year period, confirms
the acceptable outcomes after PDs in high-volume centres that
have been reported across the world.
And while there are no studies/literature available reporting or
comparing outcomes from small volume centres in India, it is
reasonable to expect that the world-wide experience of the advan-
tages of centralization of major pancreatic resectional surgery
would also be applicable in India.
Besides reporting good peri-operative outcomes after PD at the
high-volume centres in India, our study has also detected certain
variations in practice in different parts of the country. We hope
that this study will bring together pancreatic surgeons from across
the country for a collaborative effort towards formulating
evidence-based pathways for standards of care. This study should,
hopefully, encourage similar pooling and sharing of data from
various centres around the country, and serve as a starting point
in the long-term goal of establishing a credible central data-
gathering agency for the country.
Conclusions
This multi-centric study confirms the coming of age of pancreatic
resectional surgery in India. The peri-operative results from the
seven high-volume and specialist centres are encouraging. It also
guides surgeons who would like to be trained in these procedures,
in finding the appropriate centres for training.
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